Recent investigations have highlighted the evolutionary trajectory of gliomas during treatment and showed a trend from nascent to old tumors during therapy 4 , 5 , suggesting potential cellular senescence during GBM treatment.
← all excerpts
Cellular senescence-associated gene IFI16 promotes HMOX1-dependent evasion of ferroptosis and radioresistance in glioblastoma.
1
—
—